Skip Ribbon Commands
Skip to main content
Skip over global navigation links
U.S. Department of Health and Human Services

COVID-19: Coronavirus Disease 2019

In response to the 2019 Novel Coronavirus outbreak, the federal government is taking steps to protect the country.  Within the U.S. Department of Health and Human Services, the Office of the Assistant Secretary for Preparedness and Response is working with our partners to explore the development of new medical countermeasures and take other actions to enhance health security.

Monoclonal Antibody Therapeutics

​Revocation of FDA’s EUA for Bamlanivimab

The FDA has revoked the emergency use authorization (EUA) for bamlanivimab, when administered alone, for the treatment of mild-to-moderate COVID-19 in adults and certain pediatric patients who are at high risk of disease progression or hospitalization. REGEN-COV as well as bamlanivimab and etesevimab (administered together) continue to be available under EUA. Learn More >> 

 

The FDA has issued Emergency Use Authorizations for two investigational monoclonal antibody treatments. These treatments have been authorized for patients with mild to moderate cases: those who have had symptoms for 10 days or less, who are 12 years and older, and who are at high risk for progressing to severe COVID-19 and/or hospitalization. This includes people who are 65 years old or older, and who have certain chronic medical conditions. Find out what infusion site professionals patients, and healthcare providers need to know about monoclonal antibody therapeutics.

For Infusion Centers
Button (infusion centers)

For Healthcare Providers
Button (healthcare providers)

For Patients
Button (patients)



​Medical Countermeasures

BARDA COVID-19 Portfolio
Strategic National Stockpile »
Education and Training »
Federal Medical Stations »
More Initiatives »

 

COVID-19 Vaccination Workforce

HPP
Expanding the COVID-19 vaccination workforce »
Register Today! »
Eligibility »
Fact Sheet »

​Strategic National Stockpile

SNS
Strategic National Stockpile »
Education and Training »
Federal Medical Stations »
More Initiatives »

 

Healthcare and Public Health

HPP
Hospital Preparedness Program »
Healthcare Provider Resources from ASPR TRACIE »
Meeting the needs of At-Risk Individuals »
Mental and Behavioral Health »

ASPR's COVID-19 Response by the Numbers





78
COVID-19 medical
countermeasures
supported by BARDA


16K+
tons of cargo shipped by
SNS to support U.S. repatriation
efforts and state PPE needs


19
Emergency Use Authorizations
issued for BARDA-Supported
SARS CoV-2 Tests


  • This page last reviewed: May 03, 2021